Lori Lautenbach

Lori Lautenbach is an experienced professional in safety operations and pharmacovigilance with a robust background in managing safety protocols for clinical studies. Currently serving as the Director of Safety Operations at ALX Oncology since January 2024, Lori previously held the position of Safety Manager at IQVIA from May 2019 to January 2024, where responsibilities included leading safety management for large global studies. Prior roles include Manager of Pharmacovigilance at Covance and Manager of Global Safety and Pharmacovigilance at inVentiv Health, focusing on team management and departmental activities. Lori holds a Bachelor of Science degree in Registered Nursing from Oakland University, completed in January 2003.